Fingerprint
Dive into the research topics of 'Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
Ajay K. Nooka, Adam D. Cohen, Hans C. Lee, Ashraf Badros, Attaya Suvannasankha, Natalie Callander, Al Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward N. Libby, Maria Chaudhry, Malin Hultcrantz, K. Martin Kortüm, Rakesh Popat, Douglas Sborov, Shawn Hakim, Eric Lewis, Boris Gorsh, Bharat Bhushan, Astrid McKeown
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations